Wanying Lu

1.6k total citations · 3 hit papers
19 papers, 838 citations indexed

About

Wanying Lu is a scholar working on Infectious Diseases, Modeling and Simulation and Molecular Biology. According to data from OpenAlex, Wanying Lu has authored 19 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 4 papers in Modeling and Simulation and 3 papers in Molecular Biology. Recurrent topics in Wanying Lu's work include SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (6 papers) and COVID-19 epidemiological studies (4 papers). Wanying Lu is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (6 papers) and COVID-19 epidemiological studies (4 papers). Wanying Lu collaborates with scholars based in China, United States and Switzerland. Wanying Lu's co-authors include Hongjie Yu, Juan Yang, Xinhua Chen, Xiaowei Deng, Zeyao Zhao, Ruijia Sun, Qianhui Wu, Daniel T. Leung, Andrew S. Azman and Zhiyuan Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Communications.

In The Last Decade

Wanying Lu

19 papers receiving 821 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Modeling transmission of SARS-CoV-2 Omicron in China

2022 175 citations Jun Cai, Xiaowei Deng et al. Nature Medicine profile →
Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials

2021 173 citations Gang Zeng, Qianhui Wu et al. The Lancet Infectious Diseases profile →
Global landscape of SARS-CoV-2 genomic surveillance and data sharing

2022 137 citations Andrew S. Azman, Xinhua Chen et al. Nature Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wanying Lu China	12	596	237	149	95	89	19	838
Zeyao Zhao China	9	470 0.8×	278 1.2×	122 0.8×	68 0.7×	79 0.9×	15	663
Ruijia Sun China	9	446 0.7×	217 0.9×	98 0.7×	68 0.7×	73 0.8×	12	620
Cari van Schalkwyk South Africa	15	818 1.4×	164 0.7×	104 0.7×	117 1.2×	328 3.7×	42	1.1k
Simran Kaur India	8	416 0.7×	107 0.5×	193 1.3×	132 1.4×	41 0.5×	25	750
Katie E. Flight United Kingdom	6	658 1.1×	121 0.5×	202 1.4×	183 1.9×	92 1.0×	7	942
Qian He China	12	490 0.8×	90 0.4×	134 0.9×	139 1.5×	48 0.5×	34	820
Unyeong Go South Korea	10	558 0.9×	216 0.9×	128 0.9×	104 1.1×	322 3.6×	24	1.1k
Allen Wing‐Ho Chu Hong Kong	13	968 1.6×	189 0.8×	61 0.4×	148 1.6×	86 1.0×	23	1.2k
Nivedita Gupta India	13	770 1.3×	90 0.4×	133 0.9×	211 2.2×	65 0.7×	28	943
Jonathan Daniel Ip Hong Kong	18	1.3k 2.2×	223 0.9×	98 0.7×	247 2.6×	134 1.5×	35	1.6k

Countries citing papers authored by Wanying Lu

Since Specialization

Citations

This map shows the geographic impact of Wanying Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanying Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanying Lu more than expected).

Fields of papers citing papers by Wanying Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanying Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanying Lu. The network helps show where Wanying Lu may publish in the future.

Co-authorship network of co-authors of Wanying Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Wanying Lu. A scholar is included among the top collaborators of Wanying Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanying Lu. Wanying Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Liang, Yuxia, Qianli Wang, Kaige Dong, et al.. (2024). Social contact patterns and their impact on the transmission of respiratory pathogens in rural China. Infectious Disease Modelling. 10(2). 439–452. 1 indexed citations

Zhang, Juanjuan, Suoyi Tan, Peng Cheng, et al.. (2023). Heterogeneous changes in mobility in response to the SARS-CoV-2 Omicron BA.2 outbreak in Shanghai. Proceedings of the National Academy of Sciences. 120(42). e2306710120–e2306710120. 15 indexed citations

Xin, Qianqian, Qianhui Wu, Xinhua Chen, et al.. (2022). Six-month follow-up of a booster dose of CoronaVac in two single-centre phase 2 clinical trials. Nature Communications. 13(1). 3100–3100. 18 indexed citations

Chen, Xinhua, Wei Wang, Xinghui Chen, et al.. (2022). Prediction of long-term kinetics of vaccine-elicited neutralizing antibody and time-varying vaccine-specific efficacy against the SARS-CoV-2 Delta variant by clinical endpoint. BMC Medicine. 20(1). 36–36. 14 indexed citations

Cai, Jun, Xiaowei Deng, Juan Yang, et al.. (2022). Modeling transmission of SARS-CoV-2 Omicron in China. Nature Medicine. 28(7). 1468–1475. 175 indexed citations breakdown →

Azman, Andrew S., Xinhua Chen, Junyi Zou, et al.. (2022). Global landscape of SARS-CoV-2 genomic surveillance and data sharing. Nature Genetics. 54(4). 499–507. 137 indexed citations breakdown →

Lu, Wanying & Jianfu Shen. (2022). Urban Leverage and Housing Price in China. Journal of risk and financial management. 15(2). 87–87. 1 indexed citations

Lu, Wanying, et al.. (2022). Research on Penetration Testing of IoT Gateway Based on RISC- V. 422–425. 2 indexed citations

Hao, Jiming, Jinping Tian, Wanying Lu, et al.. (2022). Green Development of Industrial Parks in the Yangtze River Economic Belt. SHILAP Revista de lepidopterología. 24(1). 155–155. 1 indexed citations

10.

Chen, Xinhua, Zhiyuan Chen, Andrew S. Azman, et al.. (2021). Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Induced by Natural Infection or Vaccination: A Systematic Review and Pooled Analysis. Clinical Infectious Diseases. 74(4). 734–742. 67 indexed citations

11.

Zeng, Gang, Qianhui Wu, Hongxing Pan, et al.. (2021). Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials. The Lancet Infectious Diseases. 22(4). 483–495. 173 indexed citations breakdown →

12.

Chen, Xinhua, Zhiyuan Chen, Andrew S. Azman, et al.. (2021). Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis. The Lancet Global Health. 9(5). e598–e609. 126 indexed citations

13.

Lu, Wanying, Guoliang Zhu, Huanqin Dai, et al.. (2021). Two novel aliphatic unsaturated alcohols isolated from a pathogenic fungus Fusarium proliferatum. Synthetic and Systems Biotechnology. 6(4). 446–451. 4 indexed citations

14.

Chen, Xinhua, Zhiyuan Chen, Andrew S. Azman, et al.. (2021). Neutralizing Antibodies Against SARS-CoV-2 Variants Induced by Natural Infection or Vaccination: A Systematic Review and Individual Data Meta-Analysis. SSRN Electronic Journal. 10 indexed citations

15.

Zhang, Jinge, Shuangshuang Yang, Wanying Lu, et al.. (2021). Design, synthesis, biological evaluation, and molecular docking of 1,7-dibenzyl-substituted theophylline derivatives as novel BRD4-BD1-selective inhibitors. Medicinal Chemistry Research. 30(8). 1453–1468. 3 indexed citations

16.

Zhang, Jingyu, Biao Ren, Wanying Lu, et al.. (2020). Characterization of anti-BCG benz[α]anthraquinones and new siderophores from a Xinjiang desert–isolated rare actinomycete Nocardia sp. XJ31. Applied Microbiology and Biotechnology. 104(19). 8267–8278. 12 indexed citations

17.

Zhu, Guoliang, Zhenzhen Wang, Jingyu Zhang, et al.. (2020). Molecular networking assisted discovery and biosynthesis elucidation of the antimicrobial spiroketals epicospirocins. Chemical Communications. 56(70). 10171–10174. 13 indexed citations

18.

Chen, Zhiyuan, Andrew S. Azman, Xiaowei Deng, et al.. (2020). Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis. medRxiv. 23 indexed citations

19.

Liu, Wei, Jinping Tian, Lujun Chen, Wanying Lu, & Yang Gao. (2015). Environmental Performance Analysis of Eco‐Industrial Parks in China: A Data Envelopment Analysis Approach. Journal of Industrial Ecology. 19(6). 1070–1081. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact